B-Lymphoblastoid cell lines (B-LCL)
B-Lymphoblastoid cell lines (B-LCL), which are derived from lymphoblastoid native B lymphocytes, are established by infection with EBV (Epstein-Barr virus) and, after some cell passages, represent transformed B cell lines which can be maintained in continuous in vitro culture. As a rule, they are derived from peripheral blood and closely resemble native activated B lymphocytes as can be confirmed by their pattern of surface-expressed CD antigens.
B-LCL are, as intact cells or as DNA derived thereof, an almost unlimited source for molecular genetical, immunological and functional studies. B-LCL established from patients’ cellular material are convenient tools in tumor research and in studies of other, e.g., autoimmune diseases. A comparatively new field for the application of B-LCL is research on so-called rare diseases, because here the limited source of native cellular/genetic material can be overcome by applying these cell lines.
-
Products
-
Cell lines
-
Human cell lines
- Breast cancer cell lines
-
B lymphoblastoid cell lines
- Burkitt Lymphoma cell lines
- Urinary bladder cancer cell lines
- HaCaT cells and derivatives
- Skin cancer cell lines
- Brain cancer cell lines
- Intestine cancer cell lines
- Head-Neck cancer cell lines
- Liver cancer cell lines
- Leukemia cell lines
- Lung cancer cell lines
- Bone cancer cell lines
- Lymphoma
- Gastric cancer cell lines
- Myeloma cell lines
- Adrenal gland cancer cell lines
- Neuroblastoma cell lines
- Pancreas cancer cell lines
- Prostate cancer cell lines
- Reproductive system cancer cell lines
- Kidney cancer cell lines
- Soft tissue cancer cell lines
- Hybrid cell lines
- Spontaneously immortalized cell lines
- Transformed cell lines
- Animal cell lines
- Fluorescence tagged cell lines
-
Human cell lines
- Human primary cells
- Media & Reagents
- Nucleic acids
-
Cell lines
- Service
- Resources
- About CLS
Organism | Human |
---|---|
Tissue | Peripheral blood |
Disease | Carcinoma |
Organism | Human |
---|---|
Tissue | Peripheral blood |
Disease | Carcinoma |
Organism | Human |
---|---|
Tissue | Peripheral blood |
Disease | Carcinoma |
Organism | Human |
---|---|
Tissue | Peripheral blood |
Disease | Carcinoma |
Organism | Human |
---|---|
Tissue | Peripheral blood |
Disease | Carcinoma |
Organism | Human |
---|---|
Tissue | Peripheral blood |
Disease | Carcinoma |
Organism | Human |
---|---|
Tissue | Peripheral blood |
Disease | Carcinoma |
Organism | Human |
---|---|
Tissue | Peripheral blood |
Disease | Carcinoma |
Organism | Human |
---|---|
Tissue | Peripheral blood |
Disease | Carcinoma |
Organism | Human |
---|---|
Tissue | Peripheral blood |
Disease | Carcinoma |
Organism | Human |
---|---|
Tissue | Peripheral blood |
Disease | Carcinoma |
Organism | Human |
---|---|
Tissue | Peripheral blood |
Disease | Carcinoma |
Organism | Human |
---|---|
Tissue | Peripheral blood |
Disease | Carcinoma |
Organism | Human |
---|---|
Tissue | Peripheral blood |
Disease | Carcinoma |
Organism | Human |
---|---|
Tissue | Peripheral blood |
Disease | Carcinoma |